The finding suggests other chemo drugs, too, may be making cancer cells cause a surprising immune-system reaction.

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged ...

Researchers at the National University of Singapore have engineered a common gut bacterium to carry a chemotherapy prodrug ...

A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

Cancer drugs like cisplatin are designed to attack tumor cells, but new research shows these therapies can concentrate inside specialized molecular clusters within the nucleus, altering how ...

We are curing more cancers than we used to,” Cottrill said. “Recurrent cancers are more challenging to cure than cancers that ...

Drugmakers have poured billions of dollars into developing ADCs. The medicines are designed to deliver potent chemotherapy directly to cancer cells while sparing surrounding healthy cells. That's ...

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

Retrospective, single-center design and limited power render findings hypothesis-generating, supporting prospective ...